{"created":"2024-04-15T00:25:41.521905+00:00","id":2001679,"links":{},"metadata":{"_buckets":{"deposit":"323eb0a1-1d2d-4a44-83e1-b03b7c208d85"},"_deposit":{"created_by":2,"id":"2001679","owner":"2","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"2001679"},"status":"published"},"_oai":{"id":"oai:nihon-u.repo.nii.ac.jp:02001679","sets":["1712291514744:1712294184278:1714033216193"]},"author_link":[],"item_10006_alternative_title_1":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Mechanisms of diabetes therapy with a GLP-1 receptor agonist and a SGLT2 inhibitor in mouse models of type 2 diabetes","subitem_alternative_title_language":"en"}]},"item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2021-03-25"}]},"item_10006_degree_grantor_9":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"日本大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"32665","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_10006_degree_name_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）","subitem_degreename_language":"ja"}]},"item_10006_dissertation_number_12":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第5719号"}]},"item_10006_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.15006/32665A5719","subitem_identifier_reg_type":"JaLC"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"restricted access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_16ec"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"小池,将夫","creatorNameLang":"ja"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","filename":"Koike-Masao-1.pdf","filesize":[{"value":"182.1 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"論文の内容の要旨","objectType":"abstract","url":"https://nihon-u.repo.nii.ac.jp/record/2001679/files/Koike-Masao-1.pdf"},"version_id":"d6374de3-d2e5-4c1a-9779-978db33cab73"},{"accessrole":"open_access","filename":"Koike-Masao-2.pdf","filesize":[{"value":"169.2 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"論文審査の結果の要旨","objectType":"other","url":"https://nihon-u.repo.nii.ac.jp/record/2001679/files/Koike-Masao-2.pdf"},"version_id":"61898748-92e4-4e2c-b36b-bb6f9642c738"},{"accessrole":"open_login","filename":"Koike-Masao-3.pdf","filesize":[{"value":"4.5 MB"}],"format":"application/pdf","groups":"1","mimetype":"application/pdf","url":{"label":"論文","objectType":"fulltext","url":"https://nihon-u.repo.nii.ac.jp/record/2001679/files/Koike-Masao-3.pdf"},"version_id":"c0b2e8c3-e04a-470e-8edd-58b205ac1cff"},{"accessrole":"open_access","filename":"Koike-Masao-5.pdf","filesize":[{"value":"309.8 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"論文の要約","objectType":"summary","url":"https://nihon-u.repo.nii.ac.jp/record/2001679/files/Koike-Masao-5.pdf"},"version_id":"3a6d6d86-590b-48b7-b569-5a79d3edeeff"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"2型糖尿病","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"非アルコール性脂肪性肝疾患","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"SGLT2阻害薬","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"GLP-1受容体作動薬","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"type 2 diabetes mellitus","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"non-alcoholic fatty liver disease","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"sodium-glucose cotransporter-2 inhibitor","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"glucagon-like peptide-1 receptor agonist","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"2型糖尿病モデルマウスを用いたGLP-1受容体作動薬及びSGLT2阻害薬の薬効メカニズムの解明","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"2型糖尿病モデルマウスを用いたGLP-1受容体作動薬及びSGLT2阻害薬の薬効メカニズムの解明","subitem_title_language":"ja"}]},"item_type_id":"40001","owner":"2","path":["1714033216193"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2021-05-20"},"publish_date":"2021-05-20","publish_status":"0","recid":"2001679","relation_version_is_last":true,"title":["2型糖尿病モデルマウスを用いたGLP-1受容体作動薬及びSGLT2阻害薬の薬効メカニズムの解明"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2024-06-30T06:33:51.286702+00:00"}